CARGO Therapeutics, Inc (CRGX) Cash Funds per Single Share

Symbol and logo of brand CARGO Therapeutics, Inc (CRGX)

CARGO Therapeutics is developing innovative CAR-T therapies for lymphomas, aiming for pricing power within its niche. The change in cash per share clearly demonstrates the liquidity burn, with the indicator currently standing at 5.27. However, a narrow development profile and the high cost of manufacturing cellular products create significant risks of rapid capital burn before the completion of trials.

CRGX CARGO Therapeutics Inc.: Cash per Single Share in the range 02/21/2024 - 08/30/2025

Comprehensive metric breakdowns and analytics for CARGO Therapeutics, Inc. (CRGX)

- market price and analyst price targets:
Summary company analysis:CRGX (CARGO Therapeutics, Inc)
Finished products of cargo-tx.com

CARGO Therapeutics attracts leading geneticists through a flexible culture and generous stock options to develop CAR-T therapies. This metric reflects the ratio of total liquidity to the number of issued shares. High values confirm the existence of a financial reserve that protects capital from sharp drawdowns. However, excessive conservatism may slow business expansion. The cash per share trend clearly demonstrates this balance between stability and opportunity cost.